Dr Andrew Morrow

  • Honorary Clinical Lecturer (School of Cardiovascular & Metabolic Health)

email: Andrew.Morrow@glasgow.ac.uk

BHF Glasgow Cardiovascular Research Centre, Glasgow, G12 8TD

Import to contacts

ORCID iDhttps://orcid.org/0000-0003-4067-8249

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019
Number of items: 32.

2024

Morrow, A. et al. (2024) Zibotentan in microvascular angina: a randomized, placebo-controlled, crossover trial. Circulation, (doi: 10.1161/CIRCULATIONAHA.124.069901) (PMID:39217504) (Early Online Publication)

Glen, C. et al. (2024) Cardiovascular sequalae of trastuzumab and anthracycline in long-term survivors of breast cancer. Heart, 110(9), pp. 650-656. (doi: 10.1136/heartjnl-2023-323437) (PMID:38103912) (PMCID:PMC11041571)

Morrow, A. J. et al. (2024) Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization. Communications Medicine, 4, 32. (doi: 10.1038/s43856-024-00455-5) (PMID:38418616) (PMCID:PMC10901805)

Sidik, N. P. et al. (2024) Invasive endotyping in patients with angina and no obstructive coronary artery disease: a randomized controlled trial. Circulation, 149(1), pp. 7-23. (doi: 10.1161/CIRCULATIONAHA.123.064751) (PMID:37795617)

2023

Berry, C. et al. (2023) Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study. Heart and Mind, 7(4), pp. 235-245. (doi: 10.4103/hm.HM-D-23-00037)

Sykes, R. , Doherty, D., Morrow, A. , Mangion, K., Rushd, A. and Berry, C. (2023) NT-proBNP in patients presenting with myocardial infarction and non-obstructive coronary arteries without left ventricular systolic dysfunction. American Heart Journal Plus: Cardiology Research and Practice, 33, 100311. (doi: 10.1016/j.ahjo.2023.100311)

Mangion, K. et al. (2023) Post-COVID-19 illness and associations with sex and gender. BMC Cardiovascular Disorders, 23, 389. (doi: 10.1186/s12872-023-03412-7) (PMID:37553628) (PMCID:PMC10408208)

Morrow, A. J. , McFarlane, R. and Berry, C. (2023) Novel therapy for ischaemia with no obstructive coronary arteries. European Heart Journal, (doi: 10.1093/eurheartj/ehad391) (PMID:37377290) (Early Online Publication)

Sykes, R. A. et al. (2023) Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy. European Heart Journal: Cardiovascular Pharmacotherapy, 9(4), pp. 371-386. (doi: 10.1093/ehjcvp/pvad025) (PMID:37019821) (PMCID:PMC10236521)

Artico, J. et al. (2023) Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: a prospective, multicenter, observational study. Circulation, 147(5), pp. 364-374. (doi: 10.1161/CIRCULATIONAHA.122.060632) (PMID:36705028) (PMCID:PMC9889203)

Sykes, R. et al. (2023) Rationale and design of the effect of mineralocorticoid receptor antagonist therapy in patients with acute myocardial infarction or injury and non-obstructive coronary arteries: A registry-based, stratified-medicine, randomised, controlled trial. British Society of Cardiovascular Magnetic Resonance (BSCMR) 17th Annual Congress, Liverpool, UK, 11-12 Oct 2022. (doi: 10.1136/heartjnl-2022-BSCMR.26)

Sykes, R. et al. (2023) Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19. Open Heart, 10(1), e002192. (doi: 10.1136/openhrt-2022-002192) (PMID:36822817) (PMCID:PMC9950584)

2022

Paterson, C., Hinterberg, M. A., Morrow, A. J. , Sykes, R. , Mangion, K., Welsh, P. , McConnachie, A. , Sattar, N. , Berry, C. and Williams, S. A. (2022) Utility of a Proteomic Surrogate for Cardiovascular Outcomes to Predict and Monitor COVID-19 Induced Myocarditis. American Heart Association's 2022 Scientific Sessions and the American Heart Association's 2022 Resuscitation Science Symposium, Chicago, Illinois, USA, 04-07 Nov 2022. (doi: 10.1161/circ.146.suppl_1.12132)

Ford, T. J. et al. (2022) Coronary artery perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study. Journal of the American Heart Association, 11(19), e024492. (doi: 10.1161/JAHA.121.024492) (PMID:36129052) (PMCID:PMC9673697)

Berry, C. , Morrow, A. J. , Marzilli, M. and Pepine, C. J. (2022) What is the role of assessing ischemia to optimize therapy and outcomes for patients with stable angina and non-obstructed coronary arteries? Cardiovascular Drugs and Therapy, 36(5), pp. 1027-1038. (doi: 10.1007/s10557-021-07179-x) (PMID:33978865) (PMCID:PMC9519699)

Mangion, K. et al. (2022) Multi-system investigation of COVID-19 illness. British Cardiovascular Society Annual Conference, ‘100 years of Cardiology’, Manchester, UK, 06-08 June 2022. A122.1-A122. (doi: 10.1136/heartjnl-2022-BCS.157)

Morrow, A. J. et al. (2022) A multisystem, cardio-renal investigation of post-COVID-19 illness. Nature Medicine, 28(6), pp. 1303-1313. (doi: 10.1038/s41591-022-01837-9) (PMID:35606551) (PMCID:PMC9205780)

Abraham, G. R., Morrow, A. J. , Oliveira, J., Weir-McCall, J. R., Davenport, E. E., Berry, C. , Davenport, A. P. and Hoole, S. P. (2022) Mechanistic study of the effect of Endothelin SNPs in microvascular angina – Protocol of the PRIZE Endothelin Sub-Study. International Journal of Cardiology: Heart and Vasculature, 39, 100980. (doi: 10.1016/j.ijcha.2022.100980) (PMID:35242999) (PMCID:PMC8885580)

Ang, D. T.Y., Sidik, N. P., Morrow, A. J. , Sykes, R. , McEntegart, M. B. and Berry, C. (2022) Interventional diagnostic procedure: A practical guide for the assessment of coronary vascular function. Journal of Visualized Experiments, 181, e62265. (doi: 10.3791/62265) (PMID:35377363)

Morrow, A. et al. (2022) Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise—CISCO-21. Trials, 23, 660. (doi: 10.1186/s13063-022-06632-y) (PMID:35971155) (PMCID:PMC9376905)

2021

Berry, C. et al. (2021) Post-COVID-19 illness trajectory: a multisystem investigation [Pre-print]. Research Square, (doi: 10.21203/rs.3.rs-1053331/v1)

Morrow, A. et al. (2021) Rationale and design of the Medical Research Council Precision medicine with Zibotentan in microvascular angina (PRIZE) trial MRI sub-study. British Society of Cardiovascular Magnetic Resonance 2021 Annual Meeting, 12 October 2021. A2.1-A2. (doi: 10.1136/heartjnl-2021-BSCMR.3)

Sykes, R. , Morrow, A. and Mangion, K. (2021) The Janus of COVID-19: from registry data to prospective studies. European Heart Journal, 42(30), pp. 2951-2952. (doi: 10.1093/eurheartj/ehab238) (PMID:34166487)

Kamdar, A. , Sykes, R. , Morrow, A. , Mangion, K. and Berry, C. (2021) Cardiovascular outcomes of glucose lowering therapy in chronic kidney disease patients: a systematic review with meta-analysis. Reviews in Cardiovascular Medicine, 22(4), pp. 1479-1490. (doi: 10.31083/j.rcm2204152) (PMID:34957787)

Sykes, R. , Doherty, D., Mangion, K., Morrow, A. and Berry, C. (2021) What an interventionalist needs to know about MI with non-obstructive coronary arteries. Interventional Cardiology Review, 16, e10. (doi: 10.15420/icr.2021.10) (PMID:34188694) (PMCID:PMC8218171)

2020

Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, 116(14), pp. 2185-2196. (doi: 10.1093/cvr/cvaa209) (PMID:32702087) (PMCID:PMC7454350)

Morrow, A. J. et al. (2020) Rationale and design of the Medical Research Council precision medicine with Zibotentan in microvascular angina (PRIZE) trial. American Heart Journal, 229, pp. 70-80. (doi: 10.1016/j.ahj.2020.07.007) (PMID:32942043)

Sidik, N. P. et al. (2020) Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study. American Heart Journal, 221, pp. 48-59. (doi: 10.1016/j.ahj.2019.11.015) (PMID:31911341) (PMCID:PMC7029345)

Morrow, A. , Sidik, N. and Berry, C. (2020) ISCHEMIA: new questions from a landmark trial. Cardiovascular Research, 116(2), e23-e25. (doi: 10.1093/cvr/cvz343) (PMID:31942937) (PMCID:PMC6983679)

Sidik, N., Morrow, A. and Berry, C. (2020) Human microcirculation in ischemic heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 40(1), pp. 11-13. (doi: 10.1161/ATVBAHA.119.313579) (PMID:31869270)

2019

Morrow, A. , Ahmad, F., Steele, C., McEntegart, M. and Murdoch, D. (2019) Treating the troponin: adverse consequences of over-treatment of elevated troponin in non-coronary presentations. Scottish Medical Journal, 64(1), pp. 10-15. (doi: 10.1177/0036933018809754) (PMID:30426853)

Morrow, A. , Nordin, S., O'Boyle, P. and Berry, C. (2019) 'Acute micro-coronary syndrome': detailed coronary physiology in a patient with Takotsubo cardiomyopathy. BMJ Case Reports, 12, e229618. (doi: 10.1136/bcr-2019-229618) (PMID:31466973)

This list was generated on Sat Dec 21 08:00:36 2024 GMT.
Number of items: 32.

Articles

Morrow, A. et al. (2024) Zibotentan in microvascular angina: a randomized, placebo-controlled, crossover trial. Circulation, (doi: 10.1161/CIRCULATIONAHA.124.069901) (PMID:39217504) (Early Online Publication)

Glen, C. et al. (2024) Cardiovascular sequalae of trastuzumab and anthracycline in long-term survivors of breast cancer. Heart, 110(9), pp. 650-656. (doi: 10.1136/heartjnl-2023-323437) (PMID:38103912) (PMCID:PMC11041571)

Morrow, A. J. et al. (2024) Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization. Communications Medicine, 4, 32. (doi: 10.1038/s43856-024-00455-5) (PMID:38418616) (PMCID:PMC10901805)

Sidik, N. P. et al. (2024) Invasive endotyping in patients with angina and no obstructive coronary artery disease: a randomized controlled trial. Circulation, 149(1), pp. 7-23. (doi: 10.1161/CIRCULATIONAHA.123.064751) (PMID:37795617)

Berry, C. et al. (2023) Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study. Heart and Mind, 7(4), pp. 235-245. (doi: 10.4103/hm.HM-D-23-00037)

Sykes, R. , Doherty, D., Morrow, A. , Mangion, K., Rushd, A. and Berry, C. (2023) NT-proBNP in patients presenting with myocardial infarction and non-obstructive coronary arteries without left ventricular systolic dysfunction. American Heart Journal Plus: Cardiology Research and Practice, 33, 100311. (doi: 10.1016/j.ahjo.2023.100311)

Mangion, K. et al. (2023) Post-COVID-19 illness and associations with sex and gender. BMC Cardiovascular Disorders, 23, 389. (doi: 10.1186/s12872-023-03412-7) (PMID:37553628) (PMCID:PMC10408208)

Morrow, A. J. , McFarlane, R. and Berry, C. (2023) Novel therapy for ischaemia with no obstructive coronary arteries. European Heart Journal, (doi: 10.1093/eurheartj/ehad391) (PMID:37377290) (Early Online Publication)

Sykes, R. A. et al. (2023) Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy. European Heart Journal: Cardiovascular Pharmacotherapy, 9(4), pp. 371-386. (doi: 10.1093/ehjcvp/pvad025) (PMID:37019821) (PMCID:PMC10236521)

Artico, J. et al. (2023) Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: a prospective, multicenter, observational study. Circulation, 147(5), pp. 364-374. (doi: 10.1161/CIRCULATIONAHA.122.060632) (PMID:36705028) (PMCID:PMC9889203)

Sykes, R. et al. (2023) Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19. Open Heart, 10(1), e002192. (doi: 10.1136/openhrt-2022-002192) (PMID:36822817) (PMCID:PMC9950584)

Ford, T. J. et al. (2022) Coronary artery perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study. Journal of the American Heart Association, 11(19), e024492. (doi: 10.1161/JAHA.121.024492) (PMID:36129052) (PMCID:PMC9673697)

Berry, C. , Morrow, A. J. , Marzilli, M. and Pepine, C. J. (2022) What is the role of assessing ischemia to optimize therapy and outcomes for patients with stable angina and non-obstructed coronary arteries? Cardiovascular Drugs and Therapy, 36(5), pp. 1027-1038. (doi: 10.1007/s10557-021-07179-x) (PMID:33978865) (PMCID:PMC9519699)

Morrow, A. J. et al. (2022) A multisystem, cardio-renal investigation of post-COVID-19 illness. Nature Medicine, 28(6), pp. 1303-1313. (doi: 10.1038/s41591-022-01837-9) (PMID:35606551) (PMCID:PMC9205780)

Abraham, G. R., Morrow, A. J. , Oliveira, J., Weir-McCall, J. R., Davenport, E. E., Berry, C. , Davenport, A. P. and Hoole, S. P. (2022) Mechanistic study of the effect of Endothelin SNPs in microvascular angina – Protocol of the PRIZE Endothelin Sub-Study. International Journal of Cardiology: Heart and Vasculature, 39, 100980. (doi: 10.1016/j.ijcha.2022.100980) (PMID:35242999) (PMCID:PMC8885580)

Ang, D. T.Y., Sidik, N. P., Morrow, A. J. , Sykes, R. , McEntegart, M. B. and Berry, C. (2022) Interventional diagnostic procedure: A practical guide for the assessment of coronary vascular function. Journal of Visualized Experiments, 181, e62265. (doi: 10.3791/62265) (PMID:35377363)

Morrow, A. et al. (2022) Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise—CISCO-21. Trials, 23, 660. (doi: 10.1186/s13063-022-06632-y) (PMID:35971155) (PMCID:PMC9376905)

Berry, C. et al. (2021) Post-COVID-19 illness trajectory: a multisystem investigation [Pre-print]. Research Square, (doi: 10.21203/rs.3.rs-1053331/v1)

Sykes, R. , Morrow, A. and Mangion, K. (2021) The Janus of COVID-19: from registry data to prospective studies. European Heart Journal, 42(30), pp. 2951-2952. (doi: 10.1093/eurheartj/ehab238) (PMID:34166487)

Kamdar, A. , Sykes, R. , Morrow, A. , Mangion, K. and Berry, C. (2021) Cardiovascular outcomes of glucose lowering therapy in chronic kidney disease patients: a systematic review with meta-analysis. Reviews in Cardiovascular Medicine, 22(4), pp. 1479-1490. (doi: 10.31083/j.rcm2204152) (PMID:34957787)

Sykes, R. , Doherty, D., Mangion, K., Morrow, A. and Berry, C. (2021) What an interventionalist needs to know about MI with non-obstructive coronary arteries. Interventional Cardiology Review, 16, e10. (doi: 10.15420/icr.2021.10) (PMID:34188694) (PMCID:PMC8218171)

Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, 116(14), pp. 2185-2196. (doi: 10.1093/cvr/cvaa209) (PMID:32702087) (PMCID:PMC7454350)

Morrow, A. J. et al. (2020) Rationale and design of the Medical Research Council precision medicine with Zibotentan in microvascular angina (PRIZE) trial. American Heart Journal, 229, pp. 70-80. (doi: 10.1016/j.ahj.2020.07.007) (PMID:32942043)

Sidik, N. P. et al. (2020) Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study. American Heart Journal, 221, pp. 48-59. (doi: 10.1016/j.ahj.2019.11.015) (PMID:31911341) (PMCID:PMC7029345)

Morrow, A. , Sidik, N. and Berry, C. (2020) ISCHEMIA: new questions from a landmark trial. Cardiovascular Research, 116(2), e23-e25. (doi: 10.1093/cvr/cvz343) (PMID:31942937) (PMCID:PMC6983679)

Sidik, N., Morrow, A. and Berry, C. (2020) Human microcirculation in ischemic heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 40(1), pp. 11-13. (doi: 10.1161/ATVBAHA.119.313579) (PMID:31869270)

Morrow, A. , Ahmad, F., Steele, C., McEntegart, M. and Murdoch, D. (2019) Treating the troponin: adverse consequences of over-treatment of elevated troponin in non-coronary presentations. Scottish Medical Journal, 64(1), pp. 10-15. (doi: 10.1177/0036933018809754) (PMID:30426853)

Morrow, A. , Nordin, S., O'Boyle, P. and Berry, C. (2019) 'Acute micro-coronary syndrome': detailed coronary physiology in a patient with Takotsubo cardiomyopathy. BMJ Case Reports, 12, e229618. (doi: 10.1136/bcr-2019-229618) (PMID:31466973)

Conference or Workshop Item

Sykes, R. et al. (2023) Rationale and design of the effect of mineralocorticoid receptor antagonist therapy in patients with acute myocardial infarction or injury and non-obstructive coronary arteries: A registry-based, stratified-medicine, randomised, controlled trial. British Society of Cardiovascular Magnetic Resonance (BSCMR) 17th Annual Congress, Liverpool, UK, 11-12 Oct 2022. (doi: 10.1136/heartjnl-2022-BSCMR.26)

Paterson, C., Hinterberg, M. A., Morrow, A. J. , Sykes, R. , Mangion, K., Welsh, P. , McConnachie, A. , Sattar, N. , Berry, C. and Williams, S. A. (2022) Utility of a Proteomic Surrogate for Cardiovascular Outcomes to Predict and Monitor COVID-19 Induced Myocarditis. American Heart Association's 2022 Scientific Sessions and the American Heart Association's 2022 Resuscitation Science Symposium, Chicago, Illinois, USA, 04-07 Nov 2022. (doi: 10.1161/circ.146.suppl_1.12132)

Mangion, K. et al. (2022) Multi-system investigation of COVID-19 illness. British Cardiovascular Society Annual Conference, ‘100 years of Cardiology’, Manchester, UK, 06-08 June 2022. A122.1-A122. (doi: 10.1136/heartjnl-2022-BCS.157)

Morrow, A. et al. (2021) Rationale and design of the Medical Research Council Precision medicine with Zibotentan in microvascular angina (PRIZE) trial MRI sub-study. British Society of Cardiovascular Magnetic Resonance 2021 Annual Meeting, 12 October 2021. A2.1-A2. (doi: 10.1136/heartjnl-2021-BSCMR.3)

This list was generated on Sat Dec 21 08:00:36 2024 GMT.